ArticleCancer cell international2026

Combining an anti-HER2 antibody-drug conjugate with an anti-nectin-4 antibody-drug conjugate enhances efficacy in breast cancer and gastric cancer models.

Narjes Yazdi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.